SCIRENT was founded as a cardiovascular CRO in 2012 with the vision to help biopharmaceutical and medical technology companies develop innovative therapies for patients with cardiovascular diseases.
What makes us different from our competitors is our profound expertise in cardiovascular therapeutics and diagnostics. We have developed a highly specialized network of research sites in Europe and North America with extensive experience in a wide range of cardiovascular indications. Our clients value our lean and agile management, which makes our performance generally faster and more efficient.
We create value for our customers by functioning as an interface between our clients and sites, authorities, key opinion leaders, and other parties offering on-going advice and support to optimize processes and workflows.
Our senior leadership is involved in the day-to-day operations overseeing clinical study progress while remaining accessible to give advice or implement feedback through all phases of execution.
Our highly educated and motivated staff is passionate about solving problems that might occur during study conduct while working closely with sponsors to reach their objectives on time.
Our company collaborates with specialized cardiovascular sites with high performance in patient enrollment and care – even when it comes to demanding procedures requiring specialist know-how and equipment.
research sites with cardiovascular experience, and a strong operational structure
of our staff have an
academic degree
countries covered
full-time employees with very low turnover rate
Hans-Dirk Duengen is the founder and CEO of SCIRENT. He has collected a wealth of national and international experience in initiating and executing clinical trials as a senior cardiologist at the Charité University Hospital Berlin. Also, he is the author of numerous scientific publications.
Elvis Tahirovic is a Co-founder and Managing Director at SCIRENT. He has more than 15 years of experience as a global project manager in the healthcare sector. He is responsible for the company’s business strategy and finances.
Jovan Veskovic is a Co-Founder and the Regional Director Eastern Europe at SCIRENT. Since the beginning, he brings in his know-how and passion for managing global clinical trials. He is a management executive with degrees in Public Health and Economics.
Maximilian Posch has a strong background in academic and industry-driven research. As a clinician of internal medicine and clinical pharmacology, he has profound expertise in early phase clinical trials and cardiovascular research. In his career, he conducted more than 200 trials and co-authored numerous peer-reviewed publications.
Our site network covers 20 countries across the globe with a focus on Europe and North America.
* Partner Network
